Tech Company Financing Transactions
StemPar Sciences Funding Round
StemPar Sciences secured a investment round on 1/3/2013. Investors included Troika Ventures.
Transaction Overview
Company Name
Announced On
1/3/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Overview
StemPar Sciences is dedicated to the translation of scientific advances into new medicines to treat cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Hoyoung Huh
Chief Executive Officer
Barry Sherman
Chief Financial Officer
John Schembri
Browse more venture capital transactions:
Prev: 1/3/2013: Alvine Pharmaceuticals venture capital transaction
Next: 1/3/2013: BuzzFeed venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs